f Role of Natural Compounds as Anti-Cancer Agents

References

1. CampagnaR. PozziV. GiorginiS. MorichettiD. GoteriG. SartiniD. SerritelliE.N. EmanuelliM. Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance.Hum. Cell20233631108111910.1007/s13577‑023‑00892‑9 36897549
   [Google Scholar]
2. CampagnaR. BelloniA. PozziV. SalvucciA. NotarstefanoV. TogniL. MascittiM. SartiniD. GiorginiE. SalvoliniE. SantarelliA. Lo MuzioL. EmanuelliM. Role played by paraoxonase-2 enzyme in cell viability, proliferation and sensitivity to chemotherapy of oral squamous cell carcinoma cell lines.Int. J. Mol. Sci.202224133810.3390/ijms2401033836613780
   [Google Scholar]
3. SchiavoniV. CampagnaR. PozziV. CecatiM. MilaneseG. SartiniD. SalvoliniE. GalosiA.B. EmanuelliM. Recent advances in the management of clear cell renal cell carcinoma: novel biomarkers and targeted therapies.Cancers20231512320710.3390/cancers15123207 37370817
   [Google Scholar]
4. BrayF. LaversanneM. SungH. FerlayJ. SiegelR.L. SoerjomataramI. JemalA. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202474322926310.3322/caac.21834 38572751
   [Google Scholar]
5. AltobelliE. LatellaG. MorroniM. LiciniC. TossettaG. MazzucchelliR. ProfetaV.F. ColettiG. LeocataP. CastellucciM. GuerrieriM. PetrocelliR. De BerardisB. De PadovaM. Di LeonardoG. PaladiniA. MignosiF. QuaglioneG. FagnanoR. MarzioniD. Low HtrA1 expression in patients with long-standing ulcerative colitis and colorectal cancer.Oncol. Rep.201738141842610.3892/or.2017.5700 28586045
   [Google Scholar]
6. AntoszczakM. Mielczarek-PutaM. StrugaM. HuczyńskiA. Urea and thiourea derivatives of salinomycin as agents targeting malignant colon cancer cells.Anticancer. Agents Med. Chem.20242533033810.2174/0118715206322603241002064435 39390831
   [Google Scholar]
7. FantoneS. MarzioniD. TossettaG. NRF2/KEAP1 signaling inhibitors in gynecologic cancers.Expert Rev. Anticancer Ther.20241410.1080/14737140.2024.2438951 39636348
   [Google Scholar]
8. TossettaG. FantoneS. TogniL. SantarelliA. OlivieriF. MarzioniD. RippoM.R. Modulation of NRF2/KEAP1 signaling by phytotherapeutics in periodontitis.Antioxidants20241310127010.3390/antiox13101270 39456522
   [Google Scholar]
9. TossettaG. FantoneS. MarzioniD. MazzucchelliR. Role of natural and synthetic compounds in modulating NRF2/KEAP1 signaling pathway in prostate cancer.Cancers20231511303710.3390/cancers15113037 37296999
   [Google Scholar]
10. BacchettiT. CampagnaR. SartiniD. CecatiM. MorresiC. BellachiomaL. MartinelliE. RocchettiG. LuciniL. FerrettiG. EmanuelliM. C. spinosa L. subsp. rupestris phytochemical profile and effect on oxidative stress in normal and cancer cells.Molecules20222719648810.3390/molecules27196488 36235028
    [Google Scholar]
11. BatoolS. AsimL. Raffaq QureshiF. MasoodA. MushtaqM. SaleemR.S.Z. Molecular targets of plant-based alkaloids and polyphenolics in liver and breast cancer- an insight into anticancer drug development.Anticancer. Agents Med. Chem.20242410.2174/0118715206302216240628072554 38963106
    [Google Scholar]
12. Imbesi BellantoniM. PiccioloG. PirrottaI. IrreraN. VaccaroM. VaccaroF. SquadritoF. PallioG. Oral cavity squamous cell carcinoma: An update of the pharmacological treatment.Biomedicines2023114111210.3390/biomedicines11041112 37189730
    [Google Scholar]
13. SchiavoniV. EmanuelliM. SartiniD. SalvoliniE. PozziV. CampagnaR. Curcumin and its analogues in oral squamous cell carcinoma: State-of-the-art and therapeutic potential.Anticancer. Agents Med. Chem.20242410.2174/0118715206297840240510063330 38757321
    [Google Scholar]